Literature DB >> 168232

Studies of the elevated extracellular concentration of cyclic AMP in uremic man.

P Hamet, D A Stouder, H E Ginn, J G Hardman, G W Liddle.   

Abstract

This study was designed to elucidate the mechanism of elevation of plasma cyclic AMP in uremic man. Plasma cyclic AMP was measured in 15 normal subjects and in 18 patients with severe renal failure. In some members from both groups the kinetic parameters of the metabolism of extracellular cyclic AMP were measured. Plasma cyclic AMP was elevated from 23 nM in control subjects to 59 nM in uremic patients, regardless of the presence or absence of the kidneys or parathyroid glands. A single pass of uremic blood through a Kiil hemodialyzer decreased plasma cyclic AMP from 58 to 30 nM. The clearance of cyclic AMP by the dialyzer correlated directly with the blood flow passing through the machine. Hemodialysis for 6 h decreased plasma cyclic AMP levels in the systemic circulation by only 12%. Studies with tritiated cyclic AMP revealed a plasma clearance rate of 624 ml/min in normal subjects and of 344 ml/min in patients with uremia. Such a large decrease in plasma clearance rate cannot be explained by a failure of urinary excretion of cyclic AMP and suggests impairment of "metabolic clearance." In addition, the "plasms production rate" of cyclic AMP was 65% higher in patients with renal failure than in normal subjects. It is concluded that the elevation of plasma cyclic AMP in uremic man is due to a combination of: (a) lack of urinary excretion, (b) decreases metabolic clearance, and (c) increased production of plasma cyclic AMP.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168232      PMCID: PMC436592          DOI: 10.1172/JCI108098

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  AN AUTOMATED PROCEDURE FOR THE SIMULTANEOUS DETERMINATION OF CALCIUM AND PHOSPHORUS.

Authors:  G KESSLER; M WOLFMAN
Journal:  Clin Chem       Date:  1964-08       Impact factor: 8.327

Review 2.  REVIEW: THE USE OF ISOTOPIC STEROIDS FOR THE MEASUREMENT OF PRODUCTION RATES IN VIVO.

Authors:  J F TAIT
Journal:  J Clin Endocrinol Metab       Date:  1963-12       Impact factor: 5.958

3.  AUTOMATED AND MANUAL DIRECT METHODS FOR THE DETERMINATION OF BLOOD UREA.

Authors:  W H MARSH; B FINGERHUT; H MILLER
Journal:  Clin Chem       Date:  1965-06       Impact factor: 8.327

4.  Factors involved in the action of cyclic AMP on the permeability of mammalian kidney and toad urinary bladder.

Authors:  J S Handler; J Orloff
Journal:  Ann N Y Acad Sci       Date:  1971-12-30       Impact factor: 5.691

5.  The role of cyclic AMP in platelet function.

Authors:  B Cole; G A Robison; R C Hartmann
Journal:  Ann N Y Acad Sci       Date:  1971-12-30       Impact factor: 5.691

6.  Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function.

Authors:  E W Salzman; L Levine
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

7.  Renal effects of adenosine 3',5'-cyclic monophosphate and dibutyryl adenosine 3',5'-cyclic monophosphate. Evidence for a role for adenosine 3',5'-cyclic monophosphate in the regulation of proximal tubular sodium reabsorption.

Authors:  J R Gill; A G Casper
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

8.  Factors influencing the urinary excretion of 3',5'-adenosine monophosphate in humans.

Authors:  A L Taylor; B B Davis; L G Pawlson; J B Josimovich; D H Mintz
Journal:  J Clin Endocrinol Metab       Date:  1970-03       Impact factor: 5.958

9.  Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine.

Authors:  R W BUTCHER; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

10.  A protein binding assay for adenosine 3':5'-cyclic monophosphate.

Authors:  A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

View more
  6 in total

1.  Urinary excretion of cyclic AMP in bacterial infections.

Authors:  W J Sibbald; V M Sardesai; A Short; R F Wilson
Journal:  Intensive Care Med       Date:  1979-05       Impact factor: 17.440

2.  Zeptomole per milliliter detection and quantification of edema factor in plasma by LC-MS/MS yields insights into toxemia and the progression of inhalation anthrax.

Authors:  Renato C Lins; Anne E Boyer; Zsuzsanna Kuklenyik; Adrian R Woolfitt; Jason Goldstein; Alex R Hoffmaster; Maribel Gallegos-Candela; Clinton E Leysath; Zhaochun Chen; Judith O Brumlow; Conrad P Quinn; Dennis A Bagarozzi; Stephen H Leppla; John R Barr
Journal:  Anal Bioanal Chem       Date:  2019-03-26       Impact factor: 4.142

3.  Carbohydrate metabolism and uraemia-mechanisms for glycogenolysis and gluconeogenesis.

Authors:  W H Hörl; J Stepinski; A Heidland
Journal:  Klin Wochenschr       Date:  1980-10-01

4.  Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.

Authors:  A E Broadus; J E Mahaffey; F C Bartter; R M Neer
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

5.  Renal vein plasma adenosine 3',5'-cyclic monophosphate in renovascular hypertension.

Authors:  O Kuchel; F H Messerli; G Tolis; P Hamet; J Fraysse; P Cartier; P Roy; R Boucher; J Genest
Journal:  Can Med Assoc J       Date:  1977-05-07       Impact factor: 8.262

6.  Plasma adenosine 3':5'--cyclic monophosphate response to glucagon in uremia.

Authors:  J Vlachoyannis; W Schoeppe
Journal:  Klin Wochenschr       Date:  1982-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.